Supernus Pharmaceuticals (SUPN) Inventory (2012 - 2026)
Supernus Pharmaceuticals (SUPN) posted quarterly Inventory of $83.9 million for Q2 2026, up 90.64% year-over-year from $44.0 million in Q2 2025, and down 3.6% on a QoQ basis from $87.1 million in Q1 2026.
Supernus Pharmaceuticals (SUPN) Inventory (2012 - 2026) Analysis & Trends
Supernus Pharmaceuticals has reported Inventory for 15 years, with the latest figure at $83.9 million in Q2 2026.
- Inventory for Q2 2026 came in at $83.9 million, up 90.64% year-over-year; the trailing twelve-month figure through Jun 2026 was $83.9 million (up 90.64% YoY), and the FY2025 annual result was $82.4 million, up 51.74% from the prior year.
- Inventory declined to $83.9 million in Q2 2026, from $87.1 million in the prior quarter.
- Over five years, Inventory peaked at $91.5 million in Q4 2022 and troughed at $44.0 million in Q2 2025.
- A 5-year average of $76.6 million and a median of $82.8 million in 2022 frame the typical range for Inventory.
- The widest annual swing landed in 2025, when Inventory plunged 35.41%; it then surged 90.64% in 2026.
- A 5-year view of Inventory shows it stood at $91.5 million in 2022, then fell by 15.44% to $77.4 million in 2023, then dropped by 29.86% to $54.3 million in 2024, then jumped by 51.74% to $82.4 million in 2025, then rose by 1.87% to $83.9 million in 2026.
- Per Business Quant data, the three most recent Inventory figures were $83.9 million in Q2 2026, $87.1 million in Q1 2026, and $82.4 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 1.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 3.22 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 2.57 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 9.08 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 193.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 104.20 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.77 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 816.00 Mn |
| 10 | Supernus Pharmaceuticals | 2.74 Bn | 2.37 Bn | 185.39 Mn | 83.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 83.92 Mn |
| Mar 31, 2026 | 87.06 Mn |
| Dec 31, 2025 | 82.39 Mn |
| Sep 30, 2025 | 79.40 Mn |
| Jun 30, 2025 | 44.02 Mn |
| Mar 31, 2025 | 49.42 Mn |
| Dec 31, 2024 | 54.29 Mn |
| Sep 30, 2024 | 63.98 Mn |
| Jun 30, 2024 | 68.16 Mn |
| Mar 31, 2024 | 75.08 Mn |
| Dec 31, 2023 | 77.41 Mn |
| Sep 30, 2023 | 83.48 Mn |
| Jun 30, 2023 | 90.56 Mn |
| Mar 31, 2023 | 91.15 Mn |
| Dec 31, 2022 | 91.54 Mn |
| Sep 30, 2022 | 83.17 Mn |
| Jun 30, 2022 | 84.86 Mn |
| Mar 31, 2022 | 88.80 Mn |
| Dec 31, 2021 | 85.96 Mn |
| Sep 30, 2021 | 60.16 Mn |